A conversational agent to support remote care for individuals with substance use disorder

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

Document text

Principal Investigator: Y. Xian  Ho
Organization: DIMAGI, INC.
Fiscal Year: 2024
Award: $874,937
Funding agency: National Institute on Drug Abuse

PROJECT SUMMARY
Substance use disorder (SUD) is a significant public health challenge, and it has been
estimated that its effects on healthcare, work productivity, and criminal justice costs the US over
$600 billion annually. Engagement with the clinical care team is critical to an individual’s path to
SUD recovery; however, limited capacity of and access to addiction treatment providers and
trained staff presents an even greater challenge when faced with an increasing demand for
care. Our proposed innovation, Suzy, is a novel and intelligent chatbot designed to provide
usable, engaging, on-demand follow-up support for individuals in long-term SUD recovery
guided by their clinical care team. In this Phase II work, we will evaluate effectiveness and
implementation of Suzy with primary care patients working closely with recovery coaches who
play a critical role in following up with and engaging patients in care. We will use a mixed
methods approach to evaluate effectiveness and implementation of Suzy following three specific
aims: In Aim 1, we will follow a human-centered design approach to build a fully functional
enhanced HIPAA-compliant chatbot. In Aim 2, we will conduct a single-group mixed methods
interventional study (Study 1) with patients to evaluate Suzy’s effectiveness and
implementation. In this aim, primary care patients will be enrolled with Suzy and complete
baseline, weekly, and endline assessments over the course of a 12-week intervention period. A
purposive sample of patients and their recovery coaches will participate in qualitative interviews
to collect perspectives on Suzy user experience and patient care. In Aim 3, we will assess
sustainability and conduct cost analyses (Study 2) for the system. Results of this Phase II
project will inform further development and adoption of a cost-effective, scalable solution built on
a community-based model of care to support continuing care for individuals beyond SUD
treatment and in pursuit of long-term health and wellbeing.

Terms: <Access to Care><Active Follow-up><Acute><Address><Adherence><Adoption><Age><Appointment><Assess implementation><COVID crisis><COVID epidemic><COVID pandemic><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 years><Caring><Characteristics><Client><Clinic><Clinic Visits><Clinical><Communication><Communities><Cost Analyses><Cost Analysis><Costs and Benefits><Criminal Justice><Data><Development><Drug usage><Drugs><ED visit><ER visit><Economics><Effectiveness><Emergency care visit><Emergency department visit><Emergency hospital visit><Emergency room visit><Enrollment><Ensure><Ethnic Origin><Ethnicity><Event><Funding><Future><Gender><Goals><HIPAA><Health><Health Care Providers><Health Insurance Portability and Accountability Act><Health Personnel><Health Services Accessibility><Health Status><Healthcare><Healthcare Providers><Healthcare worker><Hospital Admission><Hospitalization><Implementation assessment><Individual><Intervention><Intervention Strategies><Intervention Studies><Interview><Investments><Kennedy Kassebaum Act><Level of Health><Link><Measures><Medicare/Medicaid><Medication><Mental Health><Mental Hygiene><Methods><Modeling><On-Line Systems><Online Systems><Outcome><Outcome Study><PL 104-191><PL104-191><Participant><Patient Care><Patient Care Delivery><Patients><Personal Satisfaction><Persons><Pharmaceutical Preparations><Phase><Play><Prisons><Productivity><Provider><Psychological Health><Public Health><Public Law 104-191><QOL><Quality of life><Race><Races><Recommendation><Recovery><Recurrence><Recurrent><Research Resources><Resources><Risk><Role><Running><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SBIR><Sampling><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severities><Small Business Innovation Research><Small Business Innovation Research Grant><Social isolation><Specialist><Speed><Structure><Substance Use Disorder><Survey Instrument><Surveys><System><Systems Analyses><Systems Analysis><Techniques><Technology><Testing><Time><Training><United States><United States Health Insurance Portability and Accountability Act><Visit><Work><access to health services><access to services><access to treatment><accessibility to health services><active followup><addiction><addictive disorder><ages><assess cost><assess effectiveness><availability of services><behavioral health><care access><care for patients><care of patients><caring for patients><chat bot><chatbot><clinical care><commercialization><conversational agent><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><cost><cost assessment><cost effective><cost effectiveness><cost estimate><cost estimation><cost evaluation><cost outcomes><craving><design><designing><determine effectiveness><developmental><digital><drug use><drug/agent><economic><effectiveness assessment><effectiveness evaluation><enroll><evaluate cost><evaluate effectiveness><evaluate implementation><evaluation of implementation><evidence base><examine cost><examine effectiveness><experience><follow up><follow-up><followed up><followup><health care><health care personnel><health care worker><health data><health level><health provider><health service access><health services availability><health workforce><healthcare personnel><human centered design><implementation cost><implementation evaluation><implementation investment><improved><indexing><indigenous community><innovate><innovation><innovative><intervention cost><intervention research><interventional research><interventional strategy><interventional study><interventions research><marginalized group><marginalized individual><marginalized people><marginalized population><medical personnel><member><novel><online computer><opiate use disorder><opioid use disorder><overdose death><overdose fatalities><participant engagement><patient engagement><peer recovery><post intervention><pragmatic effectiveness trial><pragmatic trial><primary care patient><primary care provider><prototype><providers from primary care><providers of primary care><racial><racial background><racial origin><reduced substance use><reduction in substance use><remote care><remote health care><remote healthcare><rural area><rural location><rural region><secondary analysis><secondary outcome><service availability><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><sex><social role><substance use><substance use and disorder><substance use reduction><substance use treatment><substance using><treatment access><treatment provider><uptake><usability><waiver><web based><well-being><wellbeing>